Sandoz Mobile Health Initiative: Empowering Communities Through Accessible Care

By João L. Carapinha

May 5, 2026

Sandoz has launched the Sandoz mobile health initiative in Portugal through its “Sandoz em Marcha” project, sending a mobile health unit to 16 localities over two months to deliver free screenings and health education while strengthening the role of community pharmacies as everyday access points.

Direct Community Screenings Roll Out

The unit provides cardiovascular risk checks plus metabolic, respiratory, venous, digestive, bone and skin assessments with rapid tests, followed by personalized counseling and medical referrals when needed. An accredited pharmacist training program pairs classroom learning with on-site practice, building professional skills while capturing real data on local health needs. These combined services within the Sandoz mobile health initiative target chronic disease burdens, low health literacy and uneven access to care.

Proven Model Expanded from Spain

After successful runs in Madrid and Catalonia, the Portuguese Sandoz mobile health initiative works with pharmacy groups, municipalities, patient associations and media partners to embed the mobile unit in daily community life. The unit functions as both a clinical outpost and an awareness platform, positioning pharmacies as continuous partners in prevention rather than simple dispensaries.

Data Driving Better Access Strategies

Usage figures, detected risk cases and patient feedback from the Sandoz mobile health initiative supply practical inputs for health economics evaluations of community-based prevention. Strengthened pharmacist involvement in early detection and adherence support offers evidence that can shape future reimbursement discussions and highlight how manufacturers can deliver value beyond medicines alone.

Reference url

Recent Posts

Navigating the Challenges of Patient-Centered AI Systems in Postpartum Depression Care
Patient-centered AI systems can improve care, but moving them from labs to clinics without causing harm remains a critical challenge. A recent qualitative study explored this question by capturing the perspectives of patients, healthcare professionals, and developers, using a postpartum depressio...
JNJ-4804 IBD Therapy Proves Effective for Refractory Inflammatory Bowel Disease
JNJ-4804 IBD therapy offers new hope for patients with hard-to-treat inflammatory bowel disease. This co-antibody treatment combines two proven mechanisms in a single injection. It targets IL-23 and TNF-α pathways at once. Recent Phase 2b results support its move into larger trials. Johnson &a...
Transforming Health: The Role of the South African Medical Research Council

By João L. Carapinha

May 4, 2026

South African Medical Research is driving meaningful progress in addressing the region’s most pressing health challenges. What are the priorities of the South African Medical Research Council for shaping the future of health? In a recent interview, President and CEO Ntobeko Ntusi explains how the...